MOT-CB4211 10 mg vial

MOT-CB4211 10 mg Vial is a synthetic peptide derived from the mitochondrial-encoded peptide MOTS-c (mitochondrial open reading frame of the 12S rRNA-c). It is designed for research applications focused on metabolic regulation, mitochondrial function, and cellular energy homeostasis. MOT-CB4211 is engineered to enhance the biological activity and stability of native MOTS-c, a peptide known to play a role in regulating metabolic pathways, including glucose utilization and fatty acid oxidation. Research suggests that MOTS-c and its analogs can activate AMP-activated protein kinase (AMPK), a key cellular energy sensor that promotes improved insulin sensitivity, increased energy expenditure, and metabolic flexibility. A 10 mg vial typically contains a lyophilized powder intended for reconstitution in controlled research settings. Due to its mitochondrial signaling origin, MOT-CB4211 is of particular interest in studies involving obesity, insulin resistance, and age-related metabolic decline. Preclinical data indicate potential benefits in improving glucose metabolism and reducing weight gain in metabolic disease models. Studies have demonstrated that MOTS-c regulates metabolic homeostasis and insulin sensitivity through AMPK activation: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686968/ Additional research explores mitochondrial-derived peptides and their role in aging and metabolic function: https://pubmed.ncbi.nlm.nih.gov/28604726/